Crossmark

Risk Evaluation of Acrylamide in Powder Infant Formula Based on Ingredient and Formulation in Three Critical Age Groups of Children Below 2 Years Old: Efficient Microextraction Followed by GC–MS Analysis Based on CCD

Crossref DOI link: https://doi.org/10.1007/s12161-021-02101-5

Published Online: 2021-08-15

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ghiasi, Roya

Mohammadi, Abdorreza https://orcid.org/0000-0001-6125-9081
Kamankesh, Marzieh https://orcid.org/0000-0001-7665-2521
Barzegar, Fatemeh

Jazaeri, Sahar
License Information

Text and Data Mining valid from 2021-08-15

Version of Record valid from 2021-08-15
More Information

Article History

Received: 22 January 2021

Accepted: 23 July 2021

First Online: 15 August 2021

Declarations

:

: This article does not contain studies with human participants or animals performed by any of the authors.

: Not applicable.

: Roya Ghiasi declares that she has no conflict of interest. Abdorreza Mohammadi declares that he has no conflict of interest. Marzieh Kamankesh declares that she has no conflict of interest. Fatemeh Barzegar declares that she has no conflict of interest. Sahar Jazaeri declares that she has no conflict of interest.

Document is current

Any future updates will be listed below